The present disclosure relates to a class of mammalian heat shock factor (HSF) inhibitors, to pharmaceutical compositions comprising these inhibitors as well as to methods for using the inhibitors. The inhibitors inhibit stress-induced expression from heat shock gene promoters. Furthermore, the inhibitors are cytotoxic to a variety of human cancer cells types.
[EN] INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF<br/>[FR] INHIBITEURS DU FACTEUR DE CHOC THERMIQUE ET UTILISATIONS DE CEUX-CI